Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | HTT | P42858 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | FDPS | P14324 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | APP | P05067 | 5/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | TTR | P02766 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.58 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29377794 | 0.94 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL752160 | 0.94 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL6232167 | 0.93 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL8698472 | 0.93 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL19658009 | 0.92 | FDPS (0.65) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL29446267 | 0.91 | TACR2 (0.62) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL584489 | 0.91 | TACR2 (0.62) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL30027863 | 0.90 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL30028779 | 0.90 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL2463491 | 0.89 | NPC1 (0.63) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 855 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707647-A | Preparation method of dendrobe phenol | 安徽中医药大学 | 2025-03-28 | — | — | CN | claimed |
| US-10689577-B2 | Bondable flame-retardant vanillin-derived molecules | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-23 | — | — | US | claimed |
| US-10689580-B2 | Flame-retardant vanillin-derived monomers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-23 | — | — | US | claimed |
| US-20190225888-A1 | FLAME-RETARDANT VANILLIN-DERIVED MONOMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-07-25 | — | — | US | claimed |
| US-20190106632-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-04-11 | — | — | US | claimed |
| US-20180320075-A1 | FLAME-RETARDANT VANILLIN-DERIVED MONOMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-11-08 | — | — | US | claimed |
| US-20180320073-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-11-08 | — | — | US | claimed |
| WO-2015121379-A2 | METHODS OF IMPROVING PRODUCTION OF VANILLIN | EVOLVA SA (CH) | 2015-08-20 | — | — | WO | claimed |
| EP-2460855-A2 | Oxygen scavenging compositions and packaging comprising said compositions | Constar International Inc. (US) | 2012-06-06 | — | — | EP | claimed |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | JAPAN ROYAL JELLEY CO., LTD. (JP) | 2011-11-24 | — | — | US | claimed |
| EP-1848659-A2 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | Constar International Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| CN-1876650-A | N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses | INST OF BIOLOGY SHANDONG ACADE (CN) | 2006-12-13 | — | — | CN | claimed |
| WO-2006088889-A2 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | CONSTAR INTERNATIONAL, INC. (US) | 2006-08-24 | — | — | WO | claimed |
| US-20060180790-A1 | polyesters; melt polymerization; packaging | CONSTAR INTERNATIONAL INC. (US) | 2006-08-17 | — | — | US | claimed |
| US-7084281-B2 | Synthesis of dihalohydrins and tri- and tetra-substituted olefins | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-08-01 | — | — | US | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-20040143125-A1 | Synthesis of dihalohydrins and tri- and tetra-substituted olefins | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-07-22 | — | — | US | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| US-5931995-A | Ink compositions | XEROX CORPORATION (US) | 1999-08-03 | — | — | US | claimed |
| EP-0674232-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689580-B2 | Flame-retardant vanillin-derived monomers | PFAS, VCL, PTK2 | ALDH1A1 1494/4885SMN1; SMN2 3701/4885HTT 3504/4885 |
| US-20040143125-A1 | Synthesis of dihalohydrins and tri- and tetra-substituted olefins | TALDO1, HDHD5, TKT | ALDH1A1 374/4885SMN1; SMN2 4691/4885HTT 2296/4885 |
| US-10689577-B2 | Bondable flame-retardant vanillin-derived molecules | PFAS, VCL, PTK2 | ALDH1A1 1519/4885SMN1; SMN2 4463/4885HTT 3480/4885 |
| US-20180320073-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | PFAS, VCL, PTK2 | ALDH1A1 1519/4885SMN1; SMN2 4463/4885HTT 3480/4885 |
| US-20190225888-A1 | FLAME-RETARDANT VANILLIN-DERIVED MONOMERS | PFAS, VCL, PTK2 | ALDH1A1 1494/4885SMN1; SMN2 3701/4885HTT 3504/4885 |
| US-20190106632-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | PFAS, VCL, PTK2 | ALDH1A1 1519/4885SMN1; SMN2 4463/4885HTT 3480/4885 |
| US-20180320075-A1 | FLAME-RETARDANT VANILLIN-DERIVED MONOMERS | PFAS, VCL, PTK2 | ALDH1A1 1494/4885SMN1; SMN2 3701/4885HTT 3504/4885 |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | CHAT, ACHE, PSEN1 | ALDH1A1 2200/4885SMN1; SMN2 2139/4885HTT 627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.